Ionis Pharmaceuticals, Inc. (IONS)
76.33
-0.88
(-1.14%)
USD |
NASDAQ |
Jan 16, 16:00
75.00
-1.33
(-1.74%)
After-Hours: 05:30
Ionis Pharmaceuticals Total Liabilities (Quarterly): 2.415B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 91.08B |
| Pfizer Inc. | 115.64B |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Biogen, Inc. | 11.00B |
| Cogent Biosciences, Inc. | 123.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.033B |
| Shareholders Equity (Quarterly) | 617.97M |
| Debt to Equity Ratio | 3.315 |
| Current Ratio | 2.788 |
| Net Debt Paydown Yield | -0.14% |